Yubo International Biotech annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Yubo International Biotech Depreciation & Amortization Growth & History (YBGJ)
Yubo International Biotech's depreciation and amortization was $167,581 for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $167,581 | −$2,294 | −1.35% |
| 2024 | 2024-12-31 | $169,875 | −$8,437 | −4.73% |
| 2023 | 2023-12-31 | $178,312 | $160,214 | +885.26% |
| 2022 | 2022-12-31 | $18,098 | $4,876 | +36.88% |
| 2021 | 2021-12-31 | $13,222 | $159 | +1.22% |
| 2020 · Dec 31 | 2020-12-31 | $13,063 | — | — |
Yubo International Biotech quarterly depreciation and amortization
Q1.20
Q1.21
Q2.21
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $793 | −$40,951 | −98.10% |
| Q1 2026 | 2026-03-31 | $25,745 | −$15,878 | −38.15% |
| Q4 2025 | 2025-12-31 | $44,419 | — | — |
| Q3 2025 | 2025-09-30 | $41,893 | −$4,102 | −8.92% |
| Q2 2025 | 2025-06-30 | $41,744 | $336 | +0.81% |
| Q1 2025 | 2025-03-31 | $41,623 | −$1,681 | −3.88% |
| Q3 2024 | 2024-09-30 | $45,995 | $1,789 | +4.05% |
| Q2 2024 | 2024-06-30 | $41,408 | $25,896 | +166.94% |
| Q1 2024 | 2024-03-31 | $43,304 | $36,713 | +557.02% |
| Q3 2023 | 2023-09-30 | $44,206 | $41,139 | +1341.34% |
| Q2 2023 | 2023-06-30 | $15,512 | $12,222 | +371.49% |
| Q1 2023 | 2023-03-31 | $6,591 | $1,012 | +18.14% |
| Q3 2022 | 2022-09-30 | $3,067 | −$341 | −10.01% |
| Q2 2022 | 2022-06-30 | $3,290 | −$134 | −3.91% |
| Q1 2022 | 2022-03-31 | $5,579 | $653 | +13.26% |
| Q3 2021 · Sep 30 | 2021-09-30 | $3,408 | −$8,831 | −72.15% |
| Q2 2021 · Jun 30 | 2021-06-30 | $3,424 | $1,227 | +55.85% |
| Q1 2021 · Mar 31 | 2021-03-31 | $4,926 | $3,102 | +170.07% |
| Q2 2021 · Sep 30 | 2020-09-30 | $12,239 | — | — |
| Q1 2021 · Jun 30 | 2020-06-30 | $2,197 | — | — |
| Q1 2020 · Mar 31 | 2020-03-31 | $1,824 | — | — |
Yubo International Biotech depreciation and amortization trends
Over the last five fiscal years, Yubo International Biotech's depreciation and amortization increased from $13,063 to $167,581, a change of $154,518. The latest reported quarter, Q2 2026, shows $793.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗